Heart Block

Table of Contents

1. Overview
2. Types and Classification
3. Causes and Triggers
4. Symptoms
5. ECG and Diagnostic Findings
6. Treatment
7. Natural and Lifestyle Approaches
8. Complications and Prognosis
9. Emergency Warning Signs
10. Key Research Papers
11. Connections
12. Featured Videos

Back to Table of Contents

1. Overview

Heart block — also called atrioventricular (AV) block — is a disorder of the cardiac conduction system in which the electrical impulse generated by the sinoatrial (SA) node in the right atrium is delayed or blocked from reaching the ventricles through the AV node and His-Purkinje system. The result is a slowing or dissociation of atrial and ventricular electrical activity, with varying clinical consequences ranging from asymptomatic to life-threatening hemodynamic collapse.

Under normal conditions, the electrical impulse travels from the SA node → atria → AV node → Bundle of His → left and right bundle branches → Purkinje fibers → ventricular myocardium, producing a normal PR interval of 120–200 ms on the surface ECG. A PR interval exceeding 200 ms (one large box on standard ECG paper) defines first-degree AV block. More advanced block produces dropped beats or complete AV dissociation.

Heart block is classified by severity — first, second (Mobitz type I or II), and third degree — each with distinct ECG patterns, clinical significance, and management implications. In outline:

• First-degree block: Usually benign in isolation and generally not treated; can be a normal variant in athletes
• Second-degree Mobitz I (Wenckebach): Usually benign block at the AV node level; often resolves; pacing is rarely needed
• Second-degree Mobitz II: Block below the AV node in the His bundle or bundle branches; can progress unpredictably to complete block; treated with permanent pacing even without symptoms
• Third-degree (complete) block: Complete AV dissociation; treated urgently, usually ending in a permanent pacemaker

Back to Table of Contents

2. Types and Classification

First-Degree AV Block

Defined as a PR interval >200 ms (one large box, or 5 small boxes, on standard 25 mm/sec ECG paper) on every beat, with all P waves conducted to the ventricles. The PR interval prolongation reflects delayed conduction through the AV node, but every atrial impulse eventually reaches the ventricles. No beats are "dropped."

First-degree AV block is not truly a "block" in the sense of any impulse failing to conduct — it is a conduction delay. The PR interval may be markedly prolonged (300–400 ms or more) without symptoms. It is seen in trained athletes (vagal tone), with age-related fibrosis, and in many systemic conditions affecting the AV node.

Second-Degree AV Block — Mobitz Type I (Wenckebach)

Classic Wenckebach pattern (named for the Dutch physician Karel F. Wenckebach, who described it in 1899 from radial pulse tracings, before clinical electrocardiography existed; PubMed PMID: 9890852): progressive PR interval prolongation with each successive beat until one P wave fails to conduct (dropped QRS). After the dropped beat, the cycle resets and PR interval shortens back toward baseline before the progressive prolongation begins again.

Key ECG features of Mobitz I:

• Progressive PR prolongation over consecutive beats
• The RR interval shortens progressively (due to diminishing PR increments)
• A P wave is not followed by a QRS (the dropped beat)
• The pause containing the dropped beat is less than twice the preceding RR interval
• The QRS complex is narrow (unless pre-existing bundle branch block) — block is at the AV node level

Anatomical location: AV nodal block. The AV node is richly innervated by the vagus nerve and responds to changes in autonomic tone. Wenckebach is often benign, physiologic, and reversible.

Second-Degree AV Block — Mobitz Type II

Named after the German internist Woldemar Mobitz, who classified second-degree AV block into two types in 1924; in his series type II block frequently progressed to complete block (PubMed PMID: 15339865). In Mobitz type II, P waves are conducted with a constant, unchanging PR interval until one P wave suddenly fails to conduct (dropped QRS) without any preceding PR prolongation. The block occurs below the AV node — in the His bundle or bundle branches.

Key ECG features of Mobitz II:

• Constant PR interval in conducted beats (normal or prolonged, but fixed)
• Sudden non-conducted P wave without warning PR changes
• Wide QRS complex in the majority of cases (because block is below the AV node, and bundle branch disease is usually already present)
• Conduction ratio may be 2:1 (every other P wave is blocked), 3:1, or variable

Anatomical location: Infranodal block (His bundle or bundle branches). This is the dangerous distinction: a 2001 review of second-degree block states that all correctly defined type II blocks are infranodal and that infranodal blocks require pacing regardless of form or symptoms; such block can progress unpredictably to complete heart block, and the escape rhythm that then takes over (from ventricular tissue below the block) is slow, wide-complex, and unreliable (PubMed PMID: 11155413).

2:1 AV Block — The Diagnostic Dilemma

When every other P wave is blocked (2:1 conduction), it cannot be classified as Mobitz I or Mobitz II on the ECG alone — PR behaviour cannot be observed with only one conducted beat per cycle — although the block itself can be either nodal or infranodal (PubMed PMID: 11155413). Clues to distinguish:

• Narrow QRS favors Mobitz I (nodal block)
• Wide QRS favors Mobitz II (infranodal block)
• PR interval in the conducted beat: very long PR favors Wenckebach; normal PR favors Mobitz II
• Electrophysiology study (His bundle recording) definitively localizes the block

Third-Degree (Complete) AV Block

Complete absence of AV conduction — no atrial impulses reach the ventricles. The atria and ventricles beat independently (AV dissociation). The ventricles are maintained by an escape pacemaker located below the site of block:

• Junctional escape rhythm (block at the AV node or high in the His-Purkinje system): Rate typically 40–60 bpm (PubMed PMID: 37465444); narrow QRS; relatively stable and reliable; provides adequate perfusion at rest
• Ventricular escape rhythm (infranodal block): Rate typically 20–40 bpm (PubMed PMID: 37465444); wide bizarre QRS; slow, unreliable, poorly responsive to exercise demands; causes symptoms and is potentially fatal without pacing

ECG in complete heart block: regular P waves at the (faster) atrial rate and regular QRS complexes at the (slower) escape rate, with no relationship between the two (dissociated, "marching through" independently); no consistent PR interval exists. A 2021 review defines third-degree block as the failure of each P wave to conduct to the ventricles, giving complete AV dissociation with no evidence of AV conduction (Search PubMed).

Lenegre-Lev Disease

Progressive cardiac conduction disease in adults without other structural heart disease is classically attributed to Lenegre-Lev disease — idiopathic fibrosis and sclerosis of the cardiac conduction system. Lenegre disease is named for Jean Lenegre's 1964 pathology study of bilateral bundle branch block in relation to complete heart block (PubMed PMID: 14153648); Lev disease for Maurice Lev's 1964 review of the pathology of complete AV block (PubMed PMID: 14105712), in which fibrosis reaches the conduction system from the cardiac fibrous skeleton (aging, calcific aortic stenosis, mitral annular calcification). Clinically, the two processes are indistinguishable, and the eponym is often combined. Both lead to progressive bundle branch block progressing to complete heart block over years to decades. SCN5A gene variants (sodium channel mutations) were linked to familial cardiac conduction defects in 1999 (PubMed PMID: 10471492).

Back to Table of Contents

3. Causes and Triggers

Structural and Degenerative Causes

• Lenegre-Lev disease: Age-related fibrosis of the conduction system; regarded as a common cause of chronic acquired heart block in older adults
• Ischemic heart disease: Acute MI involving the RCA (which supplies the AV node in most people, those with right-dominant circulation) → inferior MI commonly causes transient AV block; proximal LAD occlusion (supplies bundle branches) → typically causes Mobitz II or complete block with wide QRS escape, more ominous
• Calcific aortic stenosis: Calcium extends from the aortic annulus into the His bundle and bundle branches
• Surgical/procedural trauma: Post-open heart surgery (valve replacement, septal myectomy, TAVI/TAVR — new left bundle branch block and complete heart block are recognised complications of TAVI)
• Radiofrequency catheter ablation: Inadvertent injury to the AV node or His bundle during ablation procedures for arrhythmias
• Cardiomyopathy: Dilated cardiomyopathy and cardiac sarcoidosis (see Infiltrative Causes below)

Infectious Causes

• Lyme disease (Borrelia burgdorferi): Lyme carditis is an early disseminated manifestation of Lyme disease. In the 1980 description of 20 patients, 18 had fluctuating degrees of AV block and eight developed complete heart block; cardiac involvement usually lasted 3 days to 6 weeks (PubMed PMID: 6967274). A 2019 review describes high-degree AV block as the most common presentation, usually resolving with antibiotic therapy, so that a permanent pacemaker is usually unnecessary (PubMed PMID: 30765038).
• Infective endocarditis: Perivalvular abscess (particularly aortic root abscess in aortic valve endocarditis) can extend to the His bundle and AV node — new AV block in aortic endocarditis is an ominous sign of perivalvular extension requiring urgent surgical evaluation
• Myocarditis: Viral (Coxsackievirus, CMV, HIV, parvovirus B19) and autoimmune; AV block may be the presenting manifestation
• Chagas disease: Chronic chagasic cardiomyopathy is a major cause of conduction disease in Latin America; right bundle branch block (RBBB) with left anterior fascicular block is the classic Chagas pattern
• Rheumatic fever: Acute rheumatic carditis may cause first- or second-degree AV block; PR prolongation is one of the minor Jones criteria

Autoimmune Causes

• Congenital complete heart block: Neonatal lupus — maternal anti-Ro/SSA and anti-La/SSB antibodies cross the placenta and are strongly associated with complete heart block detected in utero. In a US neonatal lupus registry of 113 affected children, the block was usually found before 30 weeks of gestation (median 23 weeks), 19% of the children died (most within 3 months of birth), 63% of live-born children needed a pacemaker (35 of 107 within 9 days of life), and 16% of mothers with a later pregnancy had another affected child (PubMed PMID: 9626848)
• Systemic lupus erythematosus (SLE)
• Systemic sclerosis
• Polymyositis/dermatomyositis
• Ankylosing spondylitis and other HLA-B27-associated spondyloarthropathies — a 1997 review describes an HLA-B27-linked syndrome of severe conduction disease plus aortic regurgitation, with complete AV block located within the AV node in 95% of cases (PubMed PMID: 9341061)

Drug-Induced Heart Block

• Beta-blockers: Slow AV node conduction; overdose causes high-degree block
• Non-dihydropyridine calcium channel blockers: Verapamil and diltiazem — direct AV node depressants; interaction with beta-blockers significantly increases block risk
• Digoxin toxicity: Classic cause of all degrees of AV block including Wenckebach
• Amiodarone: Prolongs AV node refractoriness; can cause all degrees of AV block
• Adenosine: Causes transient complete heart block (used diagnostically and therapeutically for SVT); effect seconds only
• Lithium: SA and AV node dysfunction

Metabolic and Electrolyte Causes

• Hyperkalemia: Elevated extracellular potassium slows conduction through all cardiac tissue; severe hyperkalemia causes widening QRS, AV block, and eventually sine wave pattern and cardiac arrest
• Hypothyroidism
• Hypothermia

Infiltrative Causes

• Cardiac sarcoidosis: Granulomatous infiltration of the AV node and bundle branches. In a Finnish pacemaker registry of adults aged 18–55, biopsy-verified cardiac sarcoidosis or giant cell myocarditis explained 25% of initially unexplained second- or third-degree AV block, and these patients had a high rate of later serious cardiac events (PubMed PMID: 21427276); CMR and FDG-PET are used in diagnosis; corticosteroids may reverse block in early disease
• Cardiac amyloidosis: Amyloid infiltration of the conduction system causes conduction disease and heart failure
• Hemochromatosis: Iron deposition in the conduction system
• Lymphoma and metastatic malignancy

Back to Table of Contents

4. Symptoms

First-Degree AV Block

Typically asymptomatic. Occasionally, patients with very prolonged PR intervals (>300 ms) may experience symptoms from the timing mismatch between atrial and ventricular contractions ("pacemaker syndrome" physiology): reduced cardiac output, fatigue, or reduced exercise tolerance. This is termed "AV dyssynchrony" and is rare.

Second-Degree Mobitz I (Wenckebach)

Usually asymptomatic or minimally symptomatic, particularly in the setting of lower resting heart rates. Some patients note:

• Occasional awareness of a "missed beat" or "palpitation"
• Mild lightheadedness during episodes
• Fatigue with exercise if the block is rate-limiting

Second-Degree Mobitz II

More likely to be symptomatic than Mobitz I due to the unpredictable nature of dropped beats and the infranodal site of block:

• Lightheadedness and near-syncope from sudden dropped beats
• Syncope (Stokes-Adams attack) if multiple consecutive P waves fail to conduct and the escape rhythm is slow to emerge
• Fatigue and dyspnea if ventricular rate is inadequate
• Sudden cardiac arrest if progression to complete block is rapid without adequate escape rhythm

Third-Degree (Complete) Heart Block

Symptoms depend critically on the rate and reliability of the escape rhythm:

• Junctional escape (40–60 bpm): May be surprisingly well-tolerated at rest; fatigue, dyspnea on exertion (rate cannot increase with demand), lightheadedness
• Ventricular escape (20–40 bpm): Usually severely symptomatic: near-constant lightheadedness, dyspnea, and fatigue at rest; frequent syncope or pre-syncope
• Stokes-Adams attacks: Sudden, brief episodes of syncope from transient asystole as the heart pauses to establish an escape rhythm; fall without warning; rapid recovery (unlike neurological syncope); first described by William Stokes and Robert Adams in the 19th century
• Chest pain if associated with ischemia (heart block from acute MI)
• Heart failure symptoms from chronic low heart rate and reduced cardiac output

Back to Table of Contents

5. ECG and Diagnostic Findings

Surface ECG — The Primary Diagnostic Tool

The 12-lead ECG is central to diagnosing and classifying heart block. Key measurements:

• PR interval: Measured from onset of P wave to onset of QRS complex. Normal: 120–200 ms (3–5 small boxes at 25 mm/s). >200 ms = first-degree AV block. PR intervals are measured consistently in the same lead (typically lead II or V1).
• QRS duration: Normal <120 ms (<3 small boxes). Wide QRS (>120 ms) in the setting of heart block implies infranodal block or pre-existing bundle branch disease — a critical adverse prognostic sign
• P:QRS ratio: 1:1 in normal sinus rhythm and first-degree block; >1:1 in second- and third-degree block (more P waves than QRS complexes)

ECG Pattern by Type

• First-degree: Regular rhythm, constant PR >200 ms, every P followed by QRS. No dropped beats.
• Mobitz I (Wenckebach): Progressively lengthening PR, then a dropped QRS, then reset. "Longer longer longer DROP — then you have Wenckebach." The PR after the pause is the shortest in the cycle.
• Mobitz II: Fixed PR interval (may be normal or prolonged) with sudden non-conducted P wave. Wide QRS in most cases. Conduction ratio stated as atrial:ventricular (e.g., 3:2 means 3 P waves per 2 QRS complexes).
• Complete heart block: P waves and QRS complexes are entirely independent. Regular P rate (faster) and regular QRS rate (slower) with no relationship. "P waves march through, QRS complexes march through, but they never meet."

Holter Monitoring and Event Recorders

Paroxysmal or intermittent heart block — particularly relevant for unexplained syncope — may not be captured on a resting 12-lead ECG. Ambulatory monitoring options:

• 24-hour Holter monitor: adequate for frequent events
• 7- to 30-day external event monitors or patch monitors: for weekly events
• Implantable loop recorder (ILR): a small subcutaneous device that records the rhythm continuously for long periods. A 2019 review tabulates the 2018 ESC syncope guideline (PubMed PMID: 29562304) as giving a Class I indication for an ILR in an early phase of evaluation of recurrent syncope of uncertain origin, when there are no high-risk criteria requiring immediate hospitalization and a recurrence is likely within the battery life of the device (PubMed PMID: 30805041)

Electrophysiology Study (EPS)

Invasive catheter recording of His bundle electrograms (H-V interval) precisely localizes the block site:

• AH interval (atrium to His bundle): a prolonged AH indicates AV nodal delay
• HV interval (His bundle to ventricle): a prolonged HV interval points to disease below the His bundle (infranodal)
• EPS is used when the site of block is uncertain and the answer changes management (e.g., distinguishing infranodal Mobitz II from 2:1 AV block of uncertain origin)

Additional Investigations

• Serum potassium, calcium, magnesium (electrolyte causes)
• Digoxin level (if on digoxin)
• Thyroid function tests (hypothyroidism)
• Lyme serology (ELISA + Western blot) in endemic areas
• ANA, anti-Ro/SSA, anti-La/SSB (autoimmune causes; neonatal lupus workup)
• ACE level, chest CT (cardiac sarcoidosis)
• FDG-PET/CMR (cardiac sarcoidosis, myocarditis)
• Echocardiography: assess LV function, structural heart disease, pericardial disease
• Genetic testing: SCN5A, LMNA mutations in young patients with familial conduction disease

Back to Table of Contents

6. Treatment

First-Degree AV Block

First-degree block without symptoms is generally not treated. Management consists of looking for reversible causes (medication review, electrolyte correction) and follow-up ECGs for progression. In athletes with first-degree block from high vagal tone, the block may resolve with detraining.

Second-Degree Mobitz I (Wenckebach)

Management is generally expectant for asymptomatic patients with Wenckebach at the AV node level:

• Reversible causes (Lyme disease, inferior MI, drug toxicity) are looked for and treated
• AV-nodal-blocking drugs are reviewed and, where possible, withdrawn
• IV atropine is used for symptomatic acute Wenckebach (it counters vagal tone at the AV node)
• Permanent pacemaker: a 2021 review reports that the 2018 ACC/AHA/HRS guideline (PubMed PMID: 30412709) recommends against permanent pacing (Class III: harm) in people without symptoms who have first-degree block, Mobitz I, or 2:1 block believed to be at the AV node (Search PubMed); a 2001 review states that block found to be infranodal requires pacing regardless of its form or symptoms (PubMed PMID: 11155413)

Second-Degree Mobitz II

Because Mobitz II can progress unpredictably to complete heart block, it is treated with a pacemaker whether or not there are symptoms:

• Acute symptomatic Mobitz II: Atropine is often ineffective (infranodal block is not vagally mediated); transcutaneous pacing as a bridge; temporary transvenous pacemaker; IV dopamine or epinephrine may accelerate the escape rhythm temporarily
• Permanent pacemaker: a 2021 review of current recommendations states that type II second-degree block, and third-degree block without a correctable cause, are treated with pacing even in the absence of symptoms (Search PubMed)

Complete (Third-Degree) Heart Block

Complete heart block is treated with pacing. Acute management:

• Atropine: May be transiently effective if block is at the AV node (junctional escape) — limited utility in infranodal complete block
• Transcutaneous pacing: Emergency pacing delivered through pads on the chest wall; uncomfortable but life-saving bridge
• Temporary transvenous pacemaker: Catheter-based pacing electrode placed in the right ventricular apex via the jugular or subclavian vein; more reliable than transcutaneous pacing
• IV chronotropic support: Dopamine or epinephrine infusion to accelerate the escape rate while awaiting pacing
• Permanent pacemaker: the definitive treatment. Third-degree block without a correctable cause is treated with pacing even in the absence of symptoms, as a 2021 review of current recommendations states (Search PubMed).

Pacemaker Types

• Single-chamber pacemaker (VVI or VVIR): Paces only the ventricle; used in chronic AF with complete heart block, where atrial pacing is not possible
• Dual-chamber pacemaker (DDD or DDDR): Senses and paces both atrium and ventricle; maintains AV synchrony; physiologic pacing; the usual choice for AV block with sinus rhythm
• His bundle pacing: Delivers pacing directly to the His bundle, maintaining the normal ventricular activation sequence (avoiding the LBBB-like pattern of RV apex pacing). In a 2018 two-hospital observational comparison (332 His bundle vs 433 RV pacing patients), His bundle pacing was associated with fewer of the combined outcome of death, heart failure hospitalization, or upgrade to biventricular pacing (25% vs 32%) (PubMed PMID: 29535066)
• Left bundle branch pacing (LBBP): A newer technique, first reported in 2017, that paces the left bundle branch just beyond the conduction block at low and stable output, giving more physiologic activation than RV pacing (PubMed PMID: 29173611)
• Biventricular pacemaker (CRT): Used in heart block requiring pacing together with existing LV dysfunction; synchronizes RV and LV contraction
• Leadless pacemaker: Self-contained capsule implanted in the right ventricle without leads. A 2023 EHRA consensus on arrhythmias in frailty states that leadless pacemakers may prevent some implantation complications (pocket haematoma and infection, pneumothorax, lead dislodgement), while the large introducer sheaths bring vascular complications and pericardial tamponade (around 1%) (PubMed PMID: 37061780)

Reversible Causes — Treating the Underlying Disease

• Lyme carditis: a 2026 case report summarises the 2020 IDSA/AAN/ACR guideline (PubMed PMID: 33417672) as recommending intravenous ceftriaxone for hospitalized patients with high-degree AV block caused by Lyme disease, with pacing reserved for hemodynamic instability (PubMed PMID: 41817257); the block usually resolves with antibiotics, so a permanent pacemaker is usually unnecessary (PubMed PMID: 30765038)
• Drug-induced: block often resolves once the drug is withdrawn
• Acute inferior MI: AV block is usually transient; temporary pacing is used for hemodynamic compromise; a permanent pacemaker is rarely needed
• Electrolyte abnormalities: Correction of hyperkalemia, hypomagnesemia
• Cardiac sarcoidosis: Corticosteroids may reduce granulomatous infiltration of the conduction system; pacemaker for established block

Back to Table of Contents

7. Natural and Lifestyle Approaches

Important Caveat

Heart block that needs pacing is a structural electrical problem; there is no evidence that lifestyle measures or supplements reverse it or replace a pacemaker. The points below concern electrolytes and substances that can affect AV conduction. Decisions about medicines and supplements belong with a clinician.

Electrolytes and Conduction

• Magnesium: Involved in cardiac electrical stability through effects on calcium channels, sodium channels, and the Na+/K+-ATPase; low magnesium is one of the electrolyte problems corrected when conduction or rhythm disturbances are assessed; food sources include leafy greens, pumpkin seeds, almonds, dark chocolate, and avocado
• Potassium: Essential for the cardiac membrane resting potential; too much (hyperkalemia from kidney disease, supplements, or drugs) impairs conduction, and too little (hypokalemia, for example from diuretics) raises arrhythmia risk; whole-food sources include bananas, sweet potatoes, leafy greens, and avocado; potassium supplements carry a hyperkalemia risk in people with kidney disease or on potassium-raising cardiac drugs
• Calcium: Required for excitation–contraction coupling in the heart; the calcium channel blockers verapamil and diltiazem slow AV nodal conduction (see Drug-Induced Heart Block)

Drugs and Supplements That Can Affect Conduction

Several non-prescription products and supplements are reported to slow AV conduction:

• Plants and traditional preparations that contain cardiac glycosides act like digoxin and can cause AV block in excess
• Cannabis: a 2020 systematic review found AV block among the dysrhythmias reported with cannabis use, including third-degree AV block in case reports, and judged such dysrhythmias rare but potentially life-threatening (PubMed PMID: 32267189)
• Very high blood magnesium depresses cardiac conduction: one case report describes sinus arrest with a junctional escape rhythm at a serum magnesium of 13.7 mEq/L after a large dose of a magnesium citrate laxative in a 76-year-old woman (PubMed PMID: 15942092)
• Beta-blockers, non-dihydropyridine calcium channel blockers, and antiarrhythmics are the prescription drugs most often involved, which is why prescribers check for a known heart block before starting them

Exercise and Activity

How exertion affects the block depends on its level. A 2021 expert consensus statement notes that block above the His bundle generally resolves with the increased sympathetic tone of exercise, while second- or third-degree block appearing during exercise points to disease within the His-Purkinje system — rare, but associated with a poor prognosis (PubMed PMID: 34333141):

• First-degree block and Wenckebach at the AV node: block above the His bundle generally resolves with exercise
• Mobitz II or infranodal complete block: block that appears or advances during exercise points to His-Purkinje disease
• After a permanent pacemaker: rate-responsive pacemakers raise the paced heart rate with activity

Vagal Maneuver Awareness

In AV nodal block (first-degree, Wenckebach), activities that increase vagal tone transiently worsen AV nodal conduction: the Valsalva maneuver, breath-holding, straining during bowel movements, and carotid sinus pressure. These maneuvers do not affect infranodal block.

Back to Table of Contents

8. Complications and Prognosis

Progression of Block

The main prognostic concern is progression to higher-degree block, particularly from Mobitz II to complete heart block — already noted in Mobitz's 1924 series (PubMed PMID: 15339865). Progression can be sudden (during acute MI), subacute (over days in infective endocarditis), or gradual (over years in Lenegre-Lev disease). Block shown to be infranodal at EPS (below the His bundle) is, in the words of a 2001 review, an indication for pacing regardless of form or symptoms (PubMed PMID: 11155413).

Sudden Cardiac Death

The primary fatal complication of unrecognized or untreated high-degree AV block is sudden cardiac death from asystole or ventricular fibrillation during a Stokes-Adams attack. In previously healthy patients with complete heart block, death may occur before medical evaluation if the escape rhythm is absent or unreliable.

Pacemaker-Induced Cardiomyopathy

Right ventricular apex pacing (the most common pacing site) produces dyssynchronous ventricular contraction — the paced ventricle activates from the apex rather than through the normal His-Purkinje network — effectively creating an LBBB pattern. This dyssynchrony can lead to LV dysfunction: in a 2014 study of 257 patients with normal baseline function and at least 20% RV pacing, 19.5% developed pacing-induced cardiomyopathy (LVEF falling by 10 points or more to below 50%) over a mean of 3.3 years, more often men and those with a wider native QRS (PubMed PMID: 24893122). His bundle pacing and left bundle branch pacing are newer strategies that preserve synchronous ventricular activation.

Pacemaker Complications

• In a complete Danish national cohort of 5,918 device procedures, 9.5% of patients had at least one complication (PubMed PMID: 24347317)
• Lead displacement, mostly early after implantation
• Infection of the device pocket, which usually means removing the whole system and re-implanting at a new site
• Pneumothorax at lead insertion: 0.66% of 28,860 first implants in Denmark were treated with a chest tube (PubMed PMID: 22431443)
• Pacemaker syndrome (atrial-ventricular dyssynchrony from VVI pacing without AV synchrony)
• Lead fracture or insulation failure (long-term)

Prognosis

• First-degree block: Excellent long-term prognosis; does not independently increase mortality; a marker of age or structural disease
• Mobitz I: Excellent prognosis in isolation; follow-up looks for progression
• Mobitz II: Treated with a pacemaker; with pacing, prognosis is determined by the underlying disease and LV function
• Complete heart block: Without pacing, symptomatic complete heart block carries a high risk of syncope and sudden death; with a permanent pacemaker, prognosis is determined largely by the underlying heart disease and other illnesses

Back to Table of Contents

9. Emergency Warning Signs

The following are treated as medical emergencies:

• Syncope (fainting) or near-syncope: Especially sudden, without warning, and with rapid full recovery — the classic Stokes-Adams attack pattern; this is a cardiac emergency until proven otherwise
• Pulse rate below 40 bpm felt at the wrist or neck, especially with symptoms
• Feeling faint or lightheaded with slow pulse — even if not yet syncopal
• Chest pain with lightheadedness or slow pulse — may indicate heart block from acute MI
• Sudden severe shortness of breath or pulmonary edema from acute heart failure secondary to complete heart block
• Collapse with no palpable pulse — cardiac arrest from asystole, treated with CPR and emergency medical services
• Known pacemaker patient with dizziness, syncope, or persistent rates slower than the pacemaker's set lower rate — possible pacemaker malfunction
• Rash with heart symptoms in Lyme-endemic area — Lyme carditis causing AV block is treatable and time-sensitive; Lyme testing is part of the emergency work-up

Back to Table of Contents

Key Research Papers

The following peer-reviewed studies represent key evidence in heart block research and management:

1. Epstein AE, et al. 2012 ACCF/AHA/HRS Focused Update Incorporated into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities. J Am Coll Cardiol. 2013;61(3):e6–e75 — Comprehensive pacing indications guidelines. — PubMed PMID: 23265327
2. Josephson ME. Clinical Cardiac Electrophysiology, 4th ed. Chapter 4: Electrophysiologic assessment of conduction system disease. 2008 — Textbook (not indexed in PubMed); EPS data on HV interval and risk stratification. — Search PubMed
3. Brignole M, et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J. 2013;34(29):2281–2329. — PubMed PMID: 23801822
4. Kusumoto FM, et al. 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay. J Am Coll Cardiol. 2019;74(7):e51–e156. — Current US guidelines for bradycardia and heart block management. — PubMed PMID: 30412709
5. Lev M. The pathology of complete atrioventricular block. Prog Cardiovasc Dis. 1964;6:317–326 — Lev's foundational description of fibroskeletal encroachment on the conduction system. — PubMed PMID: 14105712
6. Lenegre J. Etiology and pathology of bilateral bundle branch block in relation to complete heart block. Prog Cardiovasc Dis. 1964;6:409–444 — Lenegre's description of primary sclerodegeneration. — PubMed PMID: 14153648
7. Schott JJ, et al. Cardiac conduction defects associate with mutations in SCN5A. Nat Genet. 1999;23(1):20–21 — SCN5A mutation causing familial progressive cardiac conduction disease. — PubMed PMID: 10471492
8. Steere AC, Batsford WP, Weinberg M, et al. Lyme carditis: cardiac abnormalities of Lyme disease. Ann Intern Med. 1980;93(1):8–16. — PubMed PMID: 6967274
9. Buyon JP, Hiebert R, Copel J, et al. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol. 1998;31(7):1658–1666. — PubMed PMID: 9626848
10. Barold SS, Hayes DL. Second-degree atrioventricular block: a reappraisal. Mayo Clin Proc. 2001;76(1):44–57. — PubMed PMID: 11155413
11. Bergfeldt L. HLA-B27-associated cardiac disease. Ann Intern Med. 1997;127(8 Pt 1):621–629 — AV block in ankylosing spondylitis. — PubMed PMID: 9341061
12. Huang W, Su L, Wu S, et al. A novel pacing strategy with low and stable output: pacing the left bundle branch immediately beyond the conduction block. Can J Cardiol. 2017;33(12):1736.e1–1736.e3 — First report of left bundle branch pacing. — PubMed PMID: 29173611
13. Upshaw CB Jr, Silverman ME. The Wenckebach phenomenon: a salute and comment on the centennial of its original description. Ann Intern Med. 1999;130(1):58–63. — PubMed PMID: 9890852
14. Silverman ME, Upshaw CB Jr, Lange HW. Woldemar Mobitz and his 1924 classification of second-degree atrioventricular block. Circulation. 2004;110(9):1162–1167. — PubMed PMID: 15339865
15. Yeung C, Baranchuk A. Diagnosis and treatment of Lyme carditis: JACC Review Topic of the Week. J Am Coll Cardiol. 2019;73(6):717–726. — PubMed PMID: 30765038
16. Lantos PM, Rumbaugh J, Bockenstedt LK, et al. Clinical Practice Guidelines by the IDSA, AAN, and ACR: 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease. Clin Infect Dis. 2021;72(1):e1–e48. — PubMed PMID: 33417672
17. Kandolin R, Lehtonen J, Kupari M. Cardiac sarcoidosis and giant cell myocarditis as causes of atrioventricular block in young and middle-aged adults. Circ Arrhythm Electrophysiol. 2011;4(3):303–309. — PubMed PMID: 21427276
18. Brignole M, Moya A, de Lange FJ, et al. 2018 ESC Guidelines for the diagnosis and management of syncope. Eur Heart J. 2018;39(21):1883–1948. — PubMed PMID: 29562304
19. Khurshid S, Epstein AE, Verdino RJ, et al. Incidence and predictors of right ventricular pacing-induced cardiomyopathy. Heart Rhythm. 2014;11(9):1619–1625. — PubMed PMID: 24893122
20. Abdelrahman M, Subzposh FA, Beer D, et al. Clinical outcomes of His bundle pacing compared to right ventricular pacing. J Am Coll Cardiol. 2018;71(20):2319–2330. — PubMed PMID: 29535066
21. Kirkfeldt RE, Johansen JB, Nohr EA, et al. Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark. Eur Heart J. 2014;35(18):1186–1194. — PubMed PMID: 24347317
22. Kirkfeldt RE, Johansen JB, Nohr EA, et al. Pneumothorax in cardiac pacing: a population-based cohort study of 28,860 Danish patients. Europace. 2012;14(8):1132–1138. — PubMed PMID: 22431443
23. Richards JR, Blohm E, Toles KA, et al. The association of cannabis use and cardiac dysrhythmias: a systematic review. Clin Toxicol (Phila). 2020;58(9):861–869. — PubMed PMID: 32267189
24. Kontani M, Hara A, Ohta S, Ikeda T. Hypermagnesemia induced by massive cathartic ingestion in an elderly woman without pre-existing renal dysfunction. Intern Med. 2005;44(5):448–452 (case report). — PubMed PMID: 15942092
25. Çinier G, Haseeb S, Bazoukis G, et al. Evaluation and management of asymptomatic bradyarrhythmias. Curr Cardiol Rev. 2021;17(1):60–67. — Search PubMed
26. Meloy P, Rutz D, Bhambri A. 3rd-degree atrioventricular block. J Educ Teach Emerg Med. 2022;7(2):O1–O28. — PubMed PMID: 37465444
27. Bisignani A, De Bonis S, Mancuso L, et al. Implantable loop recorder in clinical practice. J Arrhythm. 2019;35(1):25–32. — PubMed PMID: 30805041
28. Writing Committee Members; Shah MJ, Silka MJ, Avari Silva JN, et al. 2021 PACES expert consensus statement on the indications and management of cardiovascular implantable electronic devices in pediatric patients. Indian Pacing Electrophysiol J. 2021;21(6):367–393. — PubMed PMID: 34333141
29. Savelieva I, Fumagalli S, Kenny RA, et al. EHRA expert consensus document on the management of arrhythmias in frailty syndrome. Europace. 2023;25(4):1249–1276. — PubMed PMID: 37061780
30. Aryal B, Mandal P, Meyer MF. Adjuvant cilostazol therapy to help restore atrioventricular conduction in Lyme carditis. JACC Case Rep. 2026;31(10):106574 (case report). — PubMed PMID: 41817257

PubMed searches for further reading:

1. PubMed: AV block pacemaker indications
2. PubMed: Mobitz type II heart block
3. PubMed: Wenckebach AV block
4. PubMed: Complete heart block treatment
5. PubMed: Lenegre Lev disease conduction
6. PubMed: His bundle pacing outcomes

Back to Table of Contents

Connections

• Cardiology
• Arrhythmia
• Atrial Fibrillation
• Myocarditis
• Cardiomyopathy
• Heart Failure
• Cardiovascular Disease
• Coronary Artery Disease
• Endocarditis
• Hypertension
• Valvular Heart Disease
• Pericarditis
• Sarcoidosis
• Lyme Disease
• Lupus
• Magnesium
• Potassium

Back to Table of Contents

×

Featured Videos